Budge James

Chief Financial Officer

Budge James has filed 23 SEC Form 4 filings (36 transaction rows) across 1 company, with disclosures dating back to 2025. 23 of those filings fall inside the rolling window. Most recent filing: Sep 11, 2026.

On the most recent filing, Budge James is listed as Chief Financial Officer at Hinge Health, Inc. Inside the rolling window, Budge James reported no open-market purchases and 9 open-market sales totaling $9.4M in HNGE. The largest disclosed transaction in the window is a sale of 55,561 HNGE shares on Sep 10, 2026, worth $5.0M.

Companies traded

Other insiders at HNGE

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$9.4M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
HNGESale$5.0MSep 11SEC ↗
HNGESale$318KMay 27SEC ↗
HNGESale$43KMay 21SEC ↗
HNGESale$324KMay 12SEC ↗
HNGESale$465KMar 24SEC ↗
HNGESale$581KFeb 24SEC ↗
HNGESale$508KDec 23SEC ↗
HNGESale$2.1MNov 25SEC ↗
HNGESale$35KNov 21SEC ↗
Showing 1–9 of 9
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Budge James made?

Budge James has filed 23 SEC Form 4 filings (36 transaction rows) across 1 company since 2025.

Which companies does Budge James trade?

Budge James has filed SEC Form 4 disclosures for 1 company, including HNGE.

When was Budge James's most recent SEC Form 4 filing?

Budge James's most recent SEC Form 4 filing on Tracefour is dated Sep 11, 2026.

What is Budge James's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Budge James is listed as Chief Financial Officer.

What is Budge James's total buy and sell value in the current window?

Inside the rolling retention window, Budge James bought $0 and sold $9.4M based on SEC Form 4 filings.

What was Budge James's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 55,561 HNGE shares on 2026-09-10, worth $5.0M, per SEC Form 4 filings.